Articles by Kelly Lyons

Amylyx Pharmaceuticals to Present New Long-Term Data from the Pivotal CENTAUR Trial in ALS at the Muscular Dystrophy Association (MDA) Virtual Clinical & Scientific Conference March 18, 2021

– Significantly Lower Long-Term Risk of Death or Permanent Assisted Ventilation and Risk of First Hospitalization Among Participants Originally Randomized to AMX0035 Versus Placebo – Data were Consistent with CENTAUR and CENTAUR OLE Primary Outcome Measures of Statistically Significant Slowing of Functional Decline and Long-Term Survival Results Associated with the Administration of AMX0035 CAMBRIDGE, Mass. […]

Read More

Stay Connected

Get the latest news and updates from Amylyx, delivered right to your inbox.

By clicking SUBMIT, you confirm that you have read Amylyx's Privacy Policy and that you agree to receive the electronic communications from Amylyx that you've selected. You can withdraw your consent at any time.

Stay Connected

Get the latest news and updates from Amylyx, delivered right to your inbox.

By clicking SUBMIT, you confirm that you have read Amylyx's Privacy Policy and that you agree to receive the electronic communications from Amylyx that you've selected. You can withdraw your consent at any time.